Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-035167
Date:2021-05-20
Issuer: SURMODICS INC (SRDX)
Original Submission Date:

Reporting Person:

STICH JOSEPH J.
9924 WEST 74TH STREET
EDEN PRAIRIE, MN 55344

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-05-20 S 2,500 d $53.80 45,776 direct
COMMON STOCK 2021-05-20 G 1,000 d $0.00 44,776 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 sales effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 26, 2021
f2 reflects the weighted average price of 2,500 shares of common stock of surmodics, inc. sold by the reporting person in multiple transactions on may 20, 2021 with sale prices ranging from $53.42 to $54.265 per share. the reporting person undertakes to provide upon request by the u.s. securities and exchange commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
f3 includes 214 shares acquired through the employee stock purchase plan for the phase ending february 26, 2021.

Elevate your investments